Content not found!
Editor's Recommendations
Most Read Articles
Audrey Abella, 06 Feb 2018
The addition of the anti-interleukin (IL)-13 monoclonal antibody lebrikizumab to a rigorous topical corticosteroid (TCS) regimen provided significant dermatologic benefit among patients with moderate-to-severe atopic dermatitis (AD), the TREBLE* study shows.

06 Feb 2018
Clinically significant fatigue, musculoskeletal pain, sleep disturbance and depression are common in patients with post-treatment Lyme disease syndrome (PTLDS), a recent US study has shown.
31 Jan 2018
Oral tranexamic acid (TA) may help improve moderate-to-severe melasma with negligible side effects, according to a recent study.
21 Jun 2017
Oxymatrine (OMT) is a safe and effective treatment option for patients with intractable psoriasis vulgaris, a new retrospective analysis reports.